EC Number | Application | Comment | Organism |
---|---|---|---|
3.2.1.52 | medicine | GlcNAcase may be an important factor in the formation of paucimannosidic core N-glycans in Drosophila S2 cells. It may be possible to express complex glycoproteins in engineered Drosophila S2 cells by suppressing GlcNAcase in the N-glycosylation pathway | Drosophila melanogaster |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.2.1.52 | 2-acetamido-1,2-dideoxynojirimycin | GlcNAcase suppression improves the N-glycan patterns in S2 cells | Drosophila melanogaster | |
3.2.1.52 | RNAi | mediates mRNA suppression in S2 cells. About 50% reduction of Glc-NAcase activity through RNAi-mediated suppression regardless of applied dsRNA amounts compared to the case of original human erythropoietin-expressing S2 cells. GlcNAcase suppression decreases the amount of terminal Man available | Drosophila melanogaster |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.2.1.52 | membrane | - |
Drosophila melanogaster | 16020 | - |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.2.1.52 | Drosophila melanogaster | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.2.1.52 | S2 cell | transfected with human erythropoietin | Drosophila melanogaster | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.2.1.52 | 4-nitrophenyl beta-N-acetyl-D-glucosaminide + H2O | - |
Drosophila melanogaster | 4-nitrophenol + N-acetyl-beta-D-glucosamine | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.2.1.52 | beta-N-acetylglucosaminidase | - |
Drosophila melanogaster |
3.2.1.52 | GlcNAcase | - |
Drosophila melanogaster |